Skip to main content
Clinical Trials/JPRN-UMIN000006738
JPRN-UMIN000006738CompletedPhase 3

Clinical efficacy of Thrombomodulin alfa in hematological malignancy with disseminated intravascular coagulation - TA-HA

Saitama Medical Center, Saitama Medical University0 sites10 target enrollmentStarted: November 16, 2011Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
10

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
ot applicable to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1) the patients with severe bleeding such as brain, lung, and digestive tract 2) the patients with history of anaphylaxis to the contents in thrombomodulin alfa 3) 4) the inappropriate patients decided by the physicians

Investigators

Sponsor
Saitama Medical Center, Saitama Medical University

Similar Trials